Cargando…
Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
BACKGROUND: Invasive meningococcal disease (IMD) is associated with significant morbidity and mortality, thus remaining a concern for healthcare providers and the public. Evidence of the longitudinal burden of IMD and associated costs are scarce. Here we have evaluated the healthcare utilization and...
Autores principales: | Rampakakis, Emmanouil, Vaillancourt, Julie, Mursleen, Sara, Sampalis, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437085/ https://www.ncbi.nlm.nih.gov/pubmed/30763284 http://dx.doi.org/10.1097/INF.0000000000002251 |
Ejemplares similares
-
A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study
por: Madan, Mina, et al.
Publicado: (2012) -
Respiratory Virus Infection and Risk of Invasive Meningococcal Disease in Central Ontario, Canada
por: Tuite, Ashleigh R., et al.
Publicado: (2010) -
Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
por: Dang, Vica, et al.
Publicado: (2012) -
Epidemiology of invasive meningococcal disease in Canada, 2012–2019
por: Saboui, Myriam, et al.
Publicado: (2022) -
Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD: Results from the Ontario Best Practices Research Initiative (OBRI)
por: Movahedi, Mohammad, et al.
Publicado: (2019)